Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business 
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law 
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions 
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
For decades, cannabis or marijuana as it is more commonly known has been treated as an illegal substance that could land offenders in prison for a long time. After the movement to make marijuana legal gained steam, several U.S. states have since changed their tune and legalized its use. Now, a pharmaceutical company is considering developing drugs with cannabis as one of the main ingredients.
The drug company in question is GrowBlox Life Sciences LLC and it recently announced that it will be creating a new medication for curing and preventing cardiovascular diseases using marijuana as one of the ingredients, Futurism reports. One of the main driving forces behind the move is Dr. Alexander Stokes from the University of Hawaii.
In 2015, Stokes received a patent for developing a therapy method involving the treatment of heart diseases with cannabis as the principal component. When asked about it a year ago, Stokes explained that the main problems that cause heart disease in the first place have to do with increasing the strain placed on it. By giving the heart a bit of support, this workload can be redistributed.
“Many types of diseases ultimately affect the heart by making it work harder,” Stokes had said at the time. “The heart muscle compensates by getting bigger (cardiac hypertrophy). The heart becomes stiffer and less functional and eventually starts to fail. We have a way of protecting the heart with a completely new therapeutic approach—a therapy that allows the heart to compensate for the extra work it needs to perform, without losing function and failing.”
The main idea is to basically bind the receptor called TRPV1 with the cannabinoid in marijuana. Since TRPV1 is considered one of the main things that ultimately contribute to heart failure, keeping it in check will go a long way towards preventing a heart attack.
